The industry has consolidated and some manufacturers have little incentive to solve shortages because cheap generics generate thin profits
Dont beat yourself up yet
The combination of RAAS and SGLT2 inhibitors should be advocated as concomitant inhibition appears to achieve better cardiovascular and renal outcomes.40 GLP-1 Receptor Agonists The LEADER, HARMONY OUTCOMES and EXSCEL trials demonstrated the cardiovascular safety of GLP-1 RAs.1315 Meta-analyses have reported favourable cardiovascular safety profiles for GLP-1 RAs, especially in MACE and nonfatal stroke events.16,17,45 Improvements in the composite kidney outcome were also detected.45 However, the benefits were less clear-cut in comparison with SGLT2 inhibitors and somewhat conflicting across trials
Plus, a very calorie-restricted diet can cause side effects such as gallstones, an irregular heartbeat, and low electrolytes
Enriched with Coenzyme Q10 and L-Carnitine to complement your daily routine
In other words, it wants to stop companies like Hims & Hers from crafting Wegovy-like medications